Rachlin Evan Lockwood
SEC insider (Form 3/4/5 filer). CIK 0002151678. Director at Iambic Therapeutics, Inc. (IAM). 5 reported Form 4/5 transactions since Sep 2024; latest on Oct 16, 2026. Located in SAN DIEGO, CA.
Companies Rachlin Evan Lockwood has filed insider reports for
- Iambic Therapeutics, Inc. (IAM): Director
Rachlin Evan Lockwood
CIK: 0002151678
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (60.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IAM
Iambic Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Oct 16, 2026IAM
Iambic Therapeutics, Inc.
ConversionIndirect1.5M shares- - Oct 16, 2026IAM
Iambic Therapeutics, Inc.
ConversionIndirect410.8K shares- - Oct 16, 2026IAM
Iambic Therapeutics, Inc.
PurchaseIndirect718.8K shares at avg. $16.00$11.5M - Oct 16, 2026IAM
Iambic Therapeutics, Inc.
ConversionIndirect57.8K shares- - Oct 14, 2026IAM
Iambic Therapeutics, Inc.
AwardDirectStock Option (right to buy)
20.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc. | Conversion | 1,458,736 | - | $0 | Indirect |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc. | Conversion | 410,762 | - | $0 | Indirect |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc. | Purchase | 718,750 | $16.00 | $11,500,000 | Indirect |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc. | Conversion | 57,754 | - | $0 | Indirect |
| Oct 14, 2026 | IAM Iambic Therapeutics, Inc. | Award Stock Option (right to buy) | 20,300 | - | - | Direct |
1-5 of 5 transactions